ReviewClinical and translational medicine2024

Natural killer cell engagers: From bi-specific to tri-specific and tetra-specific engagers for enhanced cancer immunotherapy.

An Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.